Interbody Fusion Cage Market Expected to Reach $3012.4 Million by 2030

According to a new report published by Allied Market Research, titled, “Interbody Fusion Cage Market, by Product Type, Surgery, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030,” the global interbody fusion cages market size was valued at $1,901.67 million in 2020, and is projected to reach $3,012.47 million by 2030, registering a CAGR of 4.7% from 2021 to 2030.

Interbody fusion cage is an artificial medical device, which is utilized in spinal fusion procedures to maintain foraminal height and decompression. The interbody fusion cage is a large, hollow cylinder made up of metals such as titanium, carbon fiber, or allograft femur. The device is designed as a cage so that bone graft can be placed inside the hollow cylinder to allow a spinal fusion to occur between two vertebrae. Interbody fusion cage utilized to provide stability to the spine and the cervical region. The cages can be filled with autologous bone material to promote arthrodesis (artificial induction of joint ossification).

The growth of the Interbody fusion cages market is majorly driven by increased in demand for interbody fusion cage surgeries due to advantages that allow the surgeon to directly decompress nerves and reconstruct the spine. The key factors further driving the market growth are increase in geriatric population and surge in cases of spinal cord injuries, which might be caused due to accidents and diseases such as degenerative disk disease. In addition, upsurge in disposable income in the developing economies such as India and China contributes toward the growth of the market. However, high cost associated with spinal fusion surgeries, lack of skilled professionals, and increase in disposable incomes in emerging economies restrain the Interbody fusion cages market growth.

On the basis of product type, the lumbar cage segment was the major revenue contributor in 2020, and is anticipated to continue this trend during the forecast period, owing to increase in cervical fusion surgeries, which preserve the motion of the spine, do not need bone grafting & cervical disc replacement, and do not require a plate be placed directly in the front of the spine. On the other side, the thoracic cage segment is projected to exhibit the fastest market growth during the forecast period, owing to rise in use of thoracic cage.

On the basis of surgery, the anterior segment presently dominates the Interbody fusion cages market, and is expected to remain dominant during the forecast period, owing to ease in accessing the body from the front section.

On the basis of end user, the hospital segment presently dominates the market, and is expected to remain dominant during the forecast period, owing to increase number of spinal fusion performed at hospitals. Growing government initiatives to improve the healthcare infrastructure and expanding the middle-class population in developing nations such as India are resulting in increasing demand for quality healthcare services delivered by hospitals, thereby aiding segment growth.

North America dominated the global Interbody fusion cages market in 2020, and is expected to remain dominant throughout the forecast period with a CAGR of 3.9%. Owing to increase in geriatric population, surge in prevalence of spinal disorders, and rise in incidence of sports injuries and fatal accidents are among key factors boosting the demand for interbody fusion cage devices in North America. In addition, the presence of well-established healthcare infrastructure is expected to propel market growth in the region. Asia-Pacific is projected to register the highest CAGR of 6.0% during the forecast period, owing to its high population base and significant increase in spinal injuries.

In addition, surge in medical tourism, growth in disposable income, and rise in awareness among patients toward advanced interbody fusion devices boost the market growth in this region. Moreover, the medical device companies such as Titan Spine, Inc., and K2M have penetrated Asia-Pacific and launched several interbody fusion devices.

The major companies profiled in the Interbody fusion cages market report include Aurora Spine, Inc, B. Braun Melsungen AG, Benvenue Medical Inc., Prodorth, Ulrich Medicals, Orthofix, Medtronic Plc, Zimmer Biomet Holdings, Inc., NuVasive, Inc., and Johnson & Johnson.

Key Findings Of The Study

• By product type, the lumbar cage segment is expected to experience rapid growth in the Interbody fusion cages market, and is projected to grow at a CAGR of 3.8% from 2021 to 2030
• Thoracic cage is projected to grow at a CAGR of 6.6% during the forecast period.
• Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.0% during the forecast period.